Association of heme oxygenase 1 with the restoration of liver function after damage in murine malaria by Plasmodium yoelii

Infection and Immunity

Volumn 82, Issue 8, 2014, Pages 3113-3126

  Dey, Sumanta ^a   Mazumder, Somnath ^a   Siddiqui, Asim Azhar ^a   Iqbal, M Shameel ^a   Banerjee, Chinmoy ^a   Sarkar, Souvik ^a   De, Rudranil ^a   Goyal, Manish ^a   Bindu, Samik ^a   Bandyopadhyay, Uday ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEETHER; HEME OXYGENASE 1; PROTOPORPHYRIN COBALT; PROTOPORPHYRIN ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS; IMMUNOHISTOCHEMISTRY; IN VIVO CULTURE; LIPID PEROXIDATION; LIVER CELL; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; MULTIDRUG RESISTANCE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PARASITE CLEARANCE; PARASITEMIA; PLASMODIUM YOELII; PRIORITY JOURNAL; PROTEIN CARBONYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RODENT MALARIA; TISSUE INJURY; TREATMENT DURATION;

ANIMALS; ANTIMALARIALS; HEME OXYGENASE-1; LIVER; LIVER FUNCTION TESTS; MALARIA; MALE; MICE; MICE, INBRED BALB C; PLASMODIUM YOELII;

EID: 84904751756     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01598-14     Document Type: Article

References (106)

1. World Health Organization. 2011. The world malaria report. World Health Organization, Geneva, Switzerland.
2. Burte F, Brown BJ, Orimadegun AE, Ajetunmobi WA, Battaglia F, Ely BK, Afolabi NK, Athanasakis D, Akinkunmi F, Kowobari O, Omokodion S, Osinusi K, Akinbami FO, Shokunbi WA, Sodeinde O, Fernandez-Reyes D. 2012. Severe childhood malaria syndromes defined by plasma proteome profiles. PLoS One 7:e49778. http://dx.doi.org/10.1371/journal.pone.0049778.
3. Dey S, Bindu S, Goyal M, Pal C, Alam A, Iqbal MS, Kumar R, Sarkar S, Bandyopadhyay U. 2012. Impact of intravascular hemolysis in malaria on liver dysfunction: involvement of hepatic free heme overload, NF-kappaB activation, and neutrophil infiltration. J. Biol. Chem. 287: 26630-26646. http://dx.doi.org/10.1074/jbc.M112.341255.
4. Portugal S, Carret C, Recker M, Armitage AE, Goncalves LA, Epiphanio S, Sullivan D, Roy C, Newbold CI, Drakesmith H, Mota MM. 2011. Host-mediated regulation of superinfection in malaria. Nat. Med. 17:732-737. http://dx.doi.org/10.1038/nm.2368.
5. Seixas E, Gozzelino R, Chora A, Ferreira A, Silva G, Larsen R, Rebelo S, Penido C, Smith NR, Coutinho A, Soares MP. 2009. Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proc. Natl. Acad. Sci. U. S. A. 106:15837-15842. http://dx.doi.org/10.1073/pnas.0903419106.
6. Guha M, Kumar S, Choubey V, Maity P, Bandyopadhyay U. 2006. Apoptosis in liver during malaria: role of oxidative stress and implication of mitochondrial pathway. FFASEB J. 20:1224-1226. http://dx.doi.org/10.1096/fj.05-5338fje.
7. Adachi K, Tsutsui H, Kashiwamura S, Seki E, Nakano H, Takeuchi O, Takeda K, Okumura K, Van Kaer L, Okamura H, Akira S, Nakanishi K. 2001. Plasmodium berghei infection in mice induces liver injury by an IL-12 and Toll-like receptor/myeloid differentiation factor 88 dependent mechanism. J. Immunol. 167:5928-5934. http://dx.doi.org /10.4049/jimmunol.167.10.5928.
8. Adachi K, Tsutsui H, Seki E, Nakano H, Takeda K, Okumura K, Van Kaer L, Nakanishi K. 2004. Contribution of CD1d-unrestricted hepatic DX5+ NKT cells to liver injury in Plasmodium berghei-parasitized erythrocyte-injected mice. Int. Immunol. 16:787-798. http://dx.doi.org /10.1093/intimm/dxh080.
9. Kochar DK, Agarwal P, Kochar SK, Jain R, Rawat N, Pokharna RK, Kachhawa S, Srivastava T. 2003. Hepatocyte dysfunction and hepatic encephalopathy in Plasmodium falciparum malaria. QJM 96:505-512. http://dx.doi.org/10.1093/qjmed/hcg091.
10. Bhalla A, Suri V, Singh V. 2006. Malarial hepatopathy. J. Postgrad. Med. 52:315-320.
11. Rodriguez-Acosta A, Finol HJ, Pulido-Mendez M, Marquez A, Andrade G, Gonzalez N, Aguilar I, Giron ME, Pinto A. 1998. Liver ultrastructural pathology in mice infected with Plasmodium berghei. J. Submicrosc. Cytol. Pathol. 30:299-307.
12. Premaratna R, Gunatilake AK, de Silva NR, Tilakaratne Y, Fonseka MM, de Silva HJ. 2001. Severe hepatic dysfunction associated with falciparum malaria. Southeast Asian J. Trop. Med. Public Health 32: 70-72.
13. Rupani AB, Amarapurkar AD. 2009. Hepatic changes in fatal malaria: an emerging problem. Ann. Trop. Med. Parasitol. 103:119-127. http: //dx.doi.org/10.1179/136485909X385054.
14. Haque A, Best SE, Amante FH, Ammerdorffer A, de Labastida F, Pereira T, Ramm GA, Engwerda CR. 2011. High parasite burdens cause liver damage in mice following Plasmodium berghei ANKA infection independently of CD8(+) T cell-mediated immune pathology. Infect. Immun. 79:1882-1888. http://dx.doi.org/10.1128/IAI.01210-10.
15. Martins YC, Daniel-Ribeiro CT. 2013. A new hypothesis on the mani festation of cerebral malaria: the secret is in the liver. Med. Hypotheses 81:777-783. http://dx.doi.org/10.1016/j.mehy.2013.08.005.
16. Tangpukdee N, Thanachartwet V, Krudsood S, Luplertlop N, Pornpininworakij K, Chalermrut K, Phokham S, Kano S, Looareesuwan S, Wilairatana P. 2006. Minor liver profile dysfunctions in Plasmodium vivax, P. malaria and P. ovale patients and normalization after treatment. Korean J. Parasitol. 44:295-302. http://dx.doi.org/10.3347/kjp.2006.44.4.295.
17. Kirsner RS, Eaglstein WH. 1993. The wound healing process. Dermatol. Clin. 11:629-640.
18. Guo S, Dipietro LA. 2010. Factors affecting wound healing. J. Dent. Res. 89:219-229. http://dx.doi.org/10.1177/0022034509359125.
19. Gosain A, DiPietro LA. 2004. Aging and wound healing. World J. Surg. 28:321-326. http://dx.doi.org/10.1007/s00268-003-7397-6.
20. Naito Y, Takagi T, Yoshikawa T. 2004. Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease. Aliment. Pharmacol. Ther. 20(Suppl 1):S177-S184.
21. Naito Y, Takagi T, Uchiyama K, Yoshikawa T. 2011. Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases. J. Clin. Biochem. Nutr. 48:126-133. http://dx.doi.org/10.3164/jcbn.10-61.
22. Hull TD, Bolisetty S, Dealmeida AC, Litovsky SH, Prabhu SD, Agarwal A, George JF. 2013. Heme oxygenase-1 expression protects the heart from acute injury caused by inducible Cre recombinase. Lab. Invest. 93:868-879. http://dx.doi.org/10.1038/labinvest.2013.74.
23. Ben-Ari Z, Issan Y, Katz Y, Sultan M, Safran M, Michal LS, Nader GA, Kornowski R, Grief F, Pappo O, Hochhauser E. 2013. Induction of heme oxygenase-1 protects mouse liver from apoptotic ischemia/reperfusion injury. Apoptosis 18:547-555. http://dx.doi.org/10.1007/s10495-013-0814-x.
24. Onyiah JC, Sheikh SZ, Maharshak N, Steinbach EC, Russo SM, Kobayashi T, Mackey LC, Hansen JJ, Moeser AJ, Rawls JF, Borst LB, Otterbein LE, Plevy SE. 2013. Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance. Gastroenterology 144:789-798. http://dx.doi.org/10.1053/j.gastro.2012.12.025.
25. Li B, Lee DS, Choi HG, Kim KS, Jeong GS, An RB, Kim YC. 2012. Involvement of heme oxygenase-1 induction in the cytoprotective and immunomodulatory activities of Viola patrinii in murine hippocampal and microglia cells. Evid. Based Complement Alternat. Med. 2012: 128019. http://dx.doi.org/10.1155/2012/128019.
26. Neubauer JA, Sunderram J. 2012. Heme oxygenase-1 and chronic hypoxia. Respir. Physiol. Neurobiol. 184:178-185. http://dx.doi.org/10.1016/j.resp.2012.06.027.
27. Haines DD, Lekli I, Teissier P, Bak I, Tosaki A. 2012. Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies: focus on cardiovascular, lung, neurological and kidney disorders. Acta Physiol. (Oxf.) 204:487-501. http://dx.doi.org/10.1111/j.1748-1716.2011.02387.x.
28. Durante W. 2011. Protective role of heme oxygenase-1 against inflammation in atherosclerosis. Front. Biosci. 16:2372-2388. http://dx.doi.org /10.2741/3860.
29. Wu ML, Ho YC, Yet SF. 2011. A central role of heme oxygenase-1 in cardiovascular protection. Antioxid. Redox Signal. 15:1835-1846. http: //dx.doi.org/10.1089/ars.2010.3726.
30. Durante W. 2010. Targeting heme oxygenase-1 in vascular disease. Curr. Drug Targets 11:1504-1516. http://dx.doi.org/10.2174/1389450111009011504
31. Raval CM, Lee PJ. 2010. Heme oxygenase-1 in lung disease. Curr. Drug Targets 11:1532-1540. http://dx.doi.org/10.2174/1389450111009011532.
32. Jazwa A, Cuadrado A. 2010. Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr. Drug Targets 11:1517-1531. http://dx.doi.org/10.2174/1389450111009011517.
33. Ferenbach DA, Kluth DC, Hughes J. 2010. Hemeoxygenase-1 and renal ischaemia-reperfusion injury. Nephron Exp. Nephrol. 115:e33-e37. http://dx.doi.org/10.1159/000313828.
34. Belcher JD, Beckman JD, Balla G, Balla J, Vercellotti G. 2010. Heme degradation and vascular injury. Antioxid. Redox Signal. 12:233-248. http://dx.doi.org/10.1089/ars.2009.2822.
35. Wagener FA, van Beurden HE, von den Hoff JW, Adema GJ, Figdor CG. 2003. The heme-heme oxygenase system: a molecular switch in wound healing. Blood 102:521-528. http://dx.doi.org/10.1182/blood -2002-07-2248.
36. Wunder C, Potter RF. 2003. The heme oxygenase system: its role in liver inflammation. Curr. Drug Targets Cardiovasc. Haematol. Disord. 3:199-208. http://dx.doi.org/10.2174/1568006033481410.
37. Kumar S, Bandyopadhyay U. 2005. Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 157:175-188. http://dx.doi.org /10.1016/j.toxlet.2005.03.004.
38. Kumar S, Guha M, Choubey V, Maity P, Srivastava K, Puri SK, Bandyopadhyay U. 2008. Bilirubin inhibits Plasmodium falciparum growth through the generation of reactive oxygen species. Free Radic. Biol. Med. 44:602-613. http://dx.doi.org/10.1016/j.freeradbiomed.2007.10.057.
39. Siow RC, Sato H, Mann GE. 1999. Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc. Res. 41:385-394. http://dx.doi.org/10.1016/S0008-6363(98)00278-8.
40. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM. 1992. Ferritin: a cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267:18148-18153.
41. Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, van Kooyk Y, de Witte T, Figdor CG. 2001. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98:1802-1811. http://dx.doi.org/10.1182/blood.V98.6.1802.
42. Wagener FA, da Silva JL, Farley T, de Witte T, Kappas A, Abraham NG. 1999. Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J. Pharmacol. Exp. Ther. 291:416-423.
43. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Makino N, Ishimura Y, Suematsu M. 1999. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ. Res. 85:663-671. http://dx.doi.org/10.1161/01.RES.85.8.663.
44. Rucker M, Schafer T, Roesken F, Spitzer WJ, Bauer M, Menger MD. 2001. Reduction of inflammatory response in composite flap transfer by local stress conditioning-induced heat-shock protein 32. Surgery 129: 292-301. http://dx.doi.org/10.1067/msy.2001.111079.
45. Vachharajani TJ, Work J, Issekutz AC, Granger DN. 2000. Heme oxygenase modulates selectin expression in different regional vascular beds. Am. J. Physiol. Heart Circ. Physiol. 278:H1613-H1617.
46. Freitas A, Alves-Filho JC, Secco DD, Neto AF, Ferreira SH, BarjaFidalgo C, Cunha FQ. 2006. Heme oxygenase/carbon monoxidebiliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br. J. Pharmacol. 149:345-354. http://dx.doi.org/10.1038/sj.bjp.0706882.
47. Dovi JV, He LK, DiPietro LA. 2003. Accelerated wound closure in neutrophil-depleted mice. J. Leukoc. Biol. 73:448-455. http://dx.doi.org /10.1189/jlb.0802406.
48. Solomon VR, Puri SK, Srivastava K, Katti SB. 2005. Design and synthesis of new antimalarial agents from 4-aminoquinoline. Bioorg. Med. Chem. 13:2157-2165. http://dx.doi.org/10.1016/j.bmc.2004.12.051.
49. Goyal M, Singh P, Alam A, Das SK, Iqbal MS, Dey S, Bindu S, Pal C, Panda G, Bandyopadhyay U. 2012. Aryl aryl methyl thio arenes prevent multidrug-resistant malaria in mouse by promoting oxidative stress in parasites. Free Radic. Biol. Med. 53:129-142. http://dx.doi.org/10.1016/j.freeradbiomed.2012.04.028.
50. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262.
51. Weiss SJ, Klein R, Slivka A, Wei M. 1982. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J. Clin. Invest. 70:598-607.
52. El-Beshbishy HA, Autifi MA, Mariee AD. 2010. Green tea (Camellia sinensis) extract protects against azathioprine-induced hepatotoxicity and neutrophil infiltration in rats. Asian J. Trad. Med. 5:1-11.
53. Maity P, Bindu S, Dey S, Goyal M, Alam A, Pal C, Mitra K, Bandyopadhyay U. 2009. Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen speciesmediated mitochondrial pathology and associated apoptosis in gastric mucosa: a novel role of mitochondrial aconitase oxidation. J. Biol. Chem. 284:3058-3068. http://dx.doi.org/10.1074/jbc.M805329200.
54. Maity P, Bindu S, Dey S, Goyal M, Alam A, Pal C, Reiter R, Bandyopadhyay U. 2009. Melatonin reduces indomethacin-induced gastric mucosal cell apoptosis by preventing mitochondrial oxidative stress and the activation of mitochondrial pathway of apoptosis. J. Pineal Res. 46:314323. http://dx.doi.org/10.1111/j.1600-079X.2009.00663.x.
55. Pal C, Bindu S, Dey S, Alam A, Goyal M, Iqbal MS, Sarkar S, Kumar R, Halder KK, Debnath MC, Adhikari S, Bandyopadhyay U. 2012. Tryptamine-gallic acid hybrid prevents non-steroidal anti-inflammatory drug-induced gastropathy: correction of mitochondrial dysfunction and inhibition of apoptosis in gastric mucosal cells. J. Biol. Chem. 287:3495-3509. http://dx.doi.org/10.1074/jbc.M111.307199.
56. Pal C, Bindu S, Dey S, Alam A, Goyal M, Iqbal MS, Maity P, Adhikari SS, Bandyopadhyay U. 2010. Gallic acid prevents nonsteroidal antiinflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis. Free Radic. Biol. Med. 49:258-267. http://dx.doi.org/10.1016/j.freeradbiomed.2010.04.013.
57. Dey S, Guha M, Alam A, Goyal M, Bindu S, Pal C, Maity P, Mitra K, Bandyopadhyay U. 2009. Malarial infection develops mitochondrial pathology and mitochondrial oxidative stress to promote hepatocyte apoptosis. Free Radic. Biol. Med. 46:271-281. http://dx.doi.org/10.1016/j.freeradbiomed.2008.10.032.
58. Bindu S, Mazumder S, Dey S, Pal C, Goyal M, Alam A, Iqbal MS, Sarkar S, Azhar Siddiqui A, Banerjee C, Bandyopadhyay U. 2013. Nonsteroidal anti-inflammatory drug induces proinflammatory damage in gastric mucosa through NF-kappaB activation and neutrophil infiltration: anti-inflammatory role of heme oxygenase-1 against nonsteroidal anti-inflammatory drug. Free Radic. Biol. Med. 65:456-467. http://dx.doi.org/10.1016/j.freeradbiomed.2013.07.027.
59. Bindu S, Pal C, Dey S, Goyal M, Alam A, Iqbal MS, Dutta S, Sarkar S, Kumar R, Maity P, Bandyopadhyay U. 2011. Translocation of heme oxygenase-1 to mitochondria is a novel cytoprotective mechanism against non-steroidal anti-inflammatory drug-induced mitochondrial oxidative stress, apoptosis, and gastric mucosal injury. J. Biol. Chem. 286:39387-39402. http://dx.doi.org/10.1074/jbc.M111.279893.
60. Maity P, Bindu S, Choubey V, Alam A, Mitra K, Goyal M, Dey S, Guha M, Pal C, Bandyopadhyay U. 2008. Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal. J. Biol. Chem. 283:14391-14401. http://dx.doi.org/10.1074/jbc.M800414200.
61. Guha M, Maity P, Choubey V, Mitra K, Reiter RJ, Bandyopadhyay U. 2007. Melatonin inhibits free radical-mediated mitochondrialdependent hepatocyte apoptosis and liver damage induced during malarial infection. J. Pineal Res. 43:372-381. http://dx.doi.org/10.1111/j.1600-079X.2007.00488.x.
62. Eming SA, Krieg T, Davidson JM. 2007. Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 127:514-525. http://dx.doi.org/10.1038/sj.jid.5700701.
63. Plowe CV. 2009. The evolution of drug-resistant malaria. Trans. R. Soc. Trop. Med. Hyg. 103(Suppl 1):S11-S14. http://dx.doi.org/10.1016/j.trstmh.2008.11.002.
64. Petersen I, Eastman R, Lanzer M. 2011. Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett. 585: 1551-1562. http://dx.doi.org/10.1016/j.febslet.2011.04.042.
65. Price RN, Nosten F. 2001. Drug resistant falciparum malaria: clinical consequences and strategies for prevention. Drug Resist. Updat. 4:187196. http://dx.doi.org/10.1054/drup.2001.0195.
66. Wells TN, Alonso PL, Gutteridge WE. 2009. New medicines to improve control and contribute to the eradication of malaria. Nat. Rev. Drug Discov. 8:879-891. http://dx.doi.org/10.1038/nrd2972.
67. Reinke JM, Sorg H. 2012. Wound repair and regeneration. Eur. Surg. Res. 49:35-43. http://dx.doi.org/10.1159/000339613.
68. Li J, Chen J, Kirsner R. 2007. Pathophysiology of acute wound healing. Clin. Dermatol. 25:9-18. http://dx.doi.org/10.1016/j.clindermatol.2006.09.007.
69. Fu X, Kassim SY, Parks WC, Heinecke JW. 2003. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. J. Biol. Chem. 278:28403-28409. http://dx.doi.org/10.1074/jbc.M304739200.
70. Klebanoff SJ. 2005. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77:598-625. http://dx.doi.org/10.1189/jlb.1204697.
71. Spickett CM, Jerlich A, Panasenko OM, Arnhold J, Pitt AR, Stelmaszynska T, Schaur RJ. 2000. The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids. Acta Biochim. Pol. 47:889-899.
72. Hurst JK, Barrette WC, Jr. 1989. Leukocytic oxygen activation and microbicidal oxidative toxins. Crit. Rev. Biochem. Mol. Biol. 24:271328. http://dx.doi.org/10.3109/10409238909082555.
73. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:437-444. http://dx.doi.org/10.1172/JCI117342.
74. Naito Y, Takagi T, Yoshikawa T. 2007. Neutrophil-dependent oxidative stress in ulcerative colitis. J. Clin. Biochem. Nutr. 41:18-26. http://dx.doi.org/10.3164/jcbn.2007003.
75. Kannan K, Jain SK. 2000. Oxidative stress and apoptosis. Pathophysiology 7:153-163. http://dx.doi.org/10.1016/S0928-4680(00)00053-5.
76. Steiling H, Munz B, Werner S, Brauchle M. 1999. Different types of ROS-scavenging enzymes are expressed during cutaneous wound repair. Exp. Cell Res. 247:484-494. http://dx.doi.org/10.1006/excr.1998.4366
77. Schafer M, Werner S. 2008. Oxidative stress in normal and impaired wound repair. Pharmacol. Res. 58:165-171. http://dx.doi.org/10.1016/j.phrs.2008.06.004.
78. Kochar DK, Kaswan K, Kochar SK, Sirohi P, Pal M, Kochar A, Agrawal RP, Das A. 2006. A comparative study of regression of jaundice in patients of malaria and acute viral hepatitis. J. Vector Borne Dis. 43: 123-129.
79. Shah S, Ali L, Sattar RA, Aziz T, Ansari T, Ara J. 2009. Malarial hepatopathy in falciparum malaria. J. Coll. Physicians Surg. Pak. 19:367370.
80. Wilairatana P, Looareesuwan S, Charoenlarp P. 1994. Liver profile changes and complications in jaundiced patients with falciparum malaria. Trop. Med. Parasitol. 45:298-302.
81. Autino B, Corbett Y, Castelli F, Taramelli D. 2012. Pathogenesis of malaria in tissues and blood. Mediterr. J. Hematol. Infect. Dis. 4:e2012061. http://dx.doi.org/10.4084/MJHID.2012.061.
82. Savill J, Fadok V. 2000. Corpse clearance defines the meaning of cell death. Nature 407:784-788. http://dx.doi.org/10.1038/35037722.
83. Kurosaka K, Takahashi M, Watanabe N, Kobayashi Y. 2003. Silent cleanup of very early apoptotic cells by macrophages. J. Immunol. 171: 4672-4679. http://dx.doi.org/10.4049/jimmunol.171.9.4672.
84. Ramaiah SK, Jaeschke H. 2007. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol. Pathol. 35:757-766. http: //dx.doi.org/10.1080/01926230701584163.
85. Bian Z, Guo Y, Ha B, Zen K, Liu Y. 2012. Regulation of the inflammatory response: enhancing neutrophil infiltration under chronic inflammatory conditions. J. Immunol. 188:844-853. http://dx.doi.org/10.4049/jimmunol.1101736.
86. Chatham WW, Turkiewicz A, Blackburn WD, Jr. 1994. Determinants of neutrophil HOCl generation: ligand-dependent responses and the role of surface adhesion. J. Leukoc. Biol. 56:654-660.
87. Schlatter R, Schmich K, Lutz A, Trefzger J, Sawodny O, Ederer M, Merfort I. 2011. Modeling the TNFalpha-induced apoptosis pathway in hepatocytes. PLoS One 6:e18646. http://dx.doi.org/10.1371/journal.pone.0018646.
88. Simon HU, Haj-Yehia A, Levi-Schaffer F. 2000. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5:415-418. http://dx.doi.org/10.1023/A:1009616228304.
89. Lundvig DM, Immenschuh S, Wagener FA. 2012. Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly? Front. Pharmacol. 3:81. http://dx.doi.org/10.3389/fphar.2012.00081.
90. Guo X, Shin VY, Cho CH. 2001. Modulation of heme oxygenase in tissue injury and its implication in protection against gastrointestinal diseases. Life Sci. 69:3113-3119. http://dx.doi.org/10.1016/S0024 -3205(01)01417-5.
91. Otterbein LE, Soares MP, Yamashita K, Bach FH. 2003. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24:449-455. http://dx.doi.org/10.1016/S1471-4906(03)00181-9.
92. Ryter SW, Otterbein LE, Morse D, Choi AM. 2002. Heme oxygenase/ carbon monoxide signaling pathways: regulation and functional significance. Mol. Cell. Biochem. 234-235:249-263.
93. Bach FH. 2005. Heme oxygenase-1: a therapeutic amplification funnel. FASEB J. 19:1216-1219. http://dx.doi.org/10.1096/fj.04-3485cmt.
94. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG. 2003. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev. 55:551-571. http://dx.doi.org/10.1124/pr.55.3.5.
95. Ryter SW, Alam J, Choi AM. 2006. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86:583650. http://dx.doi.org/10.1152/physrev.00011.2005.
96. Lin YT, Chen YH, Yang YH, Jao HC, Abiko Y, Yokoyama K, Hsu C. 2010. Heme oxygenase-1 suppresses the infiltration of neutrophils in rat liver during sepsis through inactivation of p38 MAPK. Shock 34:615621. http://dx.doi.org/10.1097/SHK.0b013e3181e46ee0.
97. Gu Q, Wu Q, Jin M, Xiao Y, Xu J, Mao C, Zhao F, Zhang Y, Zhang Y. 2012. Heme oxygenase-1 alleviates mouse hepatic failure through suppression of adaptive immune responses. J. Pharmacol. Exp. Ther. 340:2-10. http://dx.doi.org/10.1124/jpet.111.186551.
98. Wei CL, Lee KH, Khoo HE, Hon WM. 2003. Expression of haem oxygenase in cirrhotic rat liver. J. Pathol. 199:324-334. http://dx.doi.org /10.1002/path.1284.
99. Nowis D, Bugajski M, Winiarska M, Bil J, Szokalska A, Salwa P, Issat T, Was H, Jozkowicz A, Dulak J, Stoklosa T, Golab J. 2008. Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice. BMC Cancer 8:197. http://dx.doi.org/10.1186/1471 -2407-8-197.
100. Hirai K, Sasahira T, Ohmori H, Fujii K, Kuniyasu H. 2007. Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int. J. Cancer 120:500-505. http://dx.doi.org/10.1002/ijc.22287.
101. Maines MD. 1981. Zinc protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim. Biophys. Acta 673:339350. http://dx.doi.org/10.1016/0304-4165(81)90465-7.
102. Ueda K, Ueyama T, Yoshida K, Kimura H, Ito T, Shimizu Y, Oka M, Tsuruo Y, Ichinose M. 2008. Adaptive HNE-Nrf2-HO-1 pathway against oxidative stress is associated with acute gastric mucosal lesions. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G460-G469. http://dx.doi.org/10.1152/ajpgi.00204.2007.
103. Wang QM, Du JL, Duan ZJ, Guo SB, Sun XY, Liu Z. 2013. Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation. World J. Gastroenterol. 19:2921-2934.
104. Yoshimura A, Wakabayashi Y, Mori T. 2010. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J. Biochem. 147: 781-792. http://dx.doi.org/10.1093/jb/mvq043.
105. Cunnington AJ, de Souza JB, Walther M, Riley EM. 2012. Malaria impairs resistance to Salmonella through heme and heme oxygenase dependent dysfunctional granulocyte mobilization. Nat. Med. 18:120127. http://dx.doi.org/10.1038/nm.2601.
106. Epiphanio S, Mikolajczak SA, Goncalves LA, Pamplona A, Portugal S, Albuquerque S, Goldberg M, Rebelo S, Anderson DG, Akinc A, Vornlocher HP, Kappe SH, Soares MP, Mota MM. 2008. Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell Host Microbe 3:331-338. http://dx.doi.org/10.1016/j.chom.2008.04.003